NCT01441141View on ClinicalTrials.gov

Genetics and Pain Severity in Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

June 17, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

December 9, 2020

Conditions
GenotypePainGenetic VariationQuantitative Sensory Testing (QST)GCH1
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT01441141 - Genetics and Pain Severity in Sickle Cell Disease | Biotech Hunter | Biotech Hunter